216 related articles for article (PubMed ID: 19129069)
1. Prevalence of type III secretion protein exoenzymes and antimicrobial susceptibility patterns from bloodstream isolates of patients with Pseudomonas aeruginosa bacteremia.
Garey KW; Vo QP; Larocco MT; Gentry LO; Tam VH
J Chemother; 2008 Dec; 20(6):714-20. PubMed ID: 19129069
[TBL] [Abstract][Full Text] [Related]
2. Difference of Type 3 secretion system (T3SS) effector gene genotypes (exoU and exoS) and its implication to antibiotics resistances in isolates of Pseudomonas aeruginosa from chronic otitis media.
Park MH; Kim SY; Roh EY; Lee HS
Auris Nasus Larynx; 2017 Jun; 44(3):258-265. PubMed ID: 27461174
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility pattern and distribution of exoU and exoS in clinical isolates of Pseudomonas aeruginosa at a Malaysian hospital.
Idris SN; Desa MN; Aziz MN; Taib NM
Southeast Asian J Trop Med Public Health; 2012 Jan; 43(1):116-23. PubMed ID: 23082561
[TBL] [Abstract][Full Text] [Related]
4. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.
Peña C; Cabot G; Gómez-Zorrilla S; Zamorano L; Ocampo-Sosa A; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Oliver A;
Clin Infect Dis; 2015 Feb; 60(4):539-48. PubMed ID: 25378459
[TBL] [Abstract][Full Text] [Related]
5. Type III secretion system-associated toxins, proteases, serotypes, and antibiotic resistance of Pseudomonas aeruginosa isolates associated with keratitis.
Zhu H; Conibear TC; Bandara R; Aliwarga Y; Stapleton F; Willcox MD
Curr Eye Res; 2006 Apr; 31(4):297-306. PubMed ID: 16603462
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of biofilm production and characterization of genes encoding type III secretion system among Pseudomonas aeruginosa isolated from burn patients.
Jabalameli F; Mirsalehian A; Khoramian B; Aligholi M; Khoramrooz SS; Asadollahi P; Taherikalani M; Emaneini M
Burns; 2012 Dec; 38(8):1192-7. PubMed ID: 22995427
[TBL] [Abstract][Full Text] [Related]
7. [Carriage of the Pseudomonas aeruginosa virulence factors and prognosis after infection].
Zhao RZ; Zheng YJ; Chen Q
Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):672-7. PubMed ID: 23158816
[TBL] [Abstract][Full Text] [Related]
8. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening.
Hu H; Harmer C; Anuj S; Wainwright CE; Manos J; Cheney J; Harbour C; Zablotska I; Turnbull L; Whitchurch CB; Grimwood K; Rose B;
Clin Microbiol Infect; 2013 Mar; 19(3):266-72. PubMed ID: 22329595
[TBL] [Abstract][Full Text] [Related]
9. High incidence of type III secretion system associated virulence factors (exoenzymes) in Pseudomonas aeruginosa isolated from Iranian burn patients.
Khodayary R; Nikokar I; Mobayen MR; Afrasiabi F; Araghian A; Elmi A; Moradzadeh M
BMC Res Notes; 2019 Jan; 12(1):28. PubMed ID: 30646938
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of type III Pseudomonas aeruginosa bacteremia.
El-Solh AA; Hattemer A; Hauser AR; Alhajhusain A; Vora H
Crit Care Med; 2012 Apr; 40(4):1157-63. PubMed ID: 22080633
[TBL] [Abstract][Full Text] [Related]
11. [Prevalence of cytotoxicity effectors in nosocomial Pseudomonas Aeruginosa strains].
Kuznetsova MV; Maksimova AV; Karpunina TI; Demakov VA
Zh Mikrobiol Epidemiol Immunobiol; 2014; (6):9-14. PubMed ID: 25816507
[TBL] [Abstract][Full Text] [Related]
12. An outbreak of fluoroquinolone-resistant Pseudomonas aeruginosa ST357 harboring the exoU gene.
Kainuma A; Momiyama K; Kimura T; Akiyama K; Inoue K; Naito Y; Kinoshita M; Shimizu M; Kato H; Shime N; Fujita N; Sawa T
J Infect Chemother; 2018 Aug; 24(8):615-622. PubMed ID: 29628388
[TBL] [Abstract][Full Text] [Related]
13. High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant "high-risk clones" of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals.
Horna G; Amaro C; Palacios A; Guerra H; Ruiz J
Sci Rep; 2019 Jul; 9(1):10874. PubMed ID: 31350412
[TBL] [Abstract][Full Text] [Related]
14. Genotypic and phenotypic analysis of type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates: evidence for a possible association between O serotypes and exo genes.
Berthelot P; Attree I; Plésiat P; Chabert J; de Bentzmann S; Pozzetto B; Grattard F;
J Infect Dis; 2003 Aug; 188(4):512-8. PubMed ID: 12898437
[TBL] [Abstract][Full Text] [Related]
15. Development of loop-mediated isothermal amplification assays for genotyping of Type III Secretion System in Pseudomonas aeruginosa.
Shi H; Chen Z; Kan J
Lett Appl Microbiol; 2015 Oct; 61(4):361-6. PubMed ID: 26219625
[TBL] [Abstract][Full Text] [Related]
16. Molecular Detection of the Virulent ExoU Genotype of Pseudomonas aeruginosa Isolated from Infected Surgical Incisions.
Hassuna NA
Surg Infect (Larchmt); 2016 Oct; 17(5):610-4. PubMed ID: 27441791
[TBL] [Abstract][Full Text] [Related]
17. Differentiation in quinolone resistance by virulence genotype in Pseudomonas aeruginosa.
Agnello M; Wong-Beringer A
PLoS One; 2012; 7(8):e42973. PubMed ID: 22905192
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa.
Feltman H; Schulert G; Khan S; Jain M; Peterson L; Hauser AR
Microbiology (Reading); 2001 Oct; 147(Pt 10):2659-2669. PubMed ID: 11577145
[TBL] [Abstract][Full Text] [Related]
19. Molecular detection of type III secretory toxins in Pseudomonas aeruginosa isolates.
Jarjees KK
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):9-14. PubMed ID: 33040805
[TBL] [Abstract][Full Text] [Related]
20. Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa.
Wong-Beringer A; Wiener-Kronish J; Lynch S; Flanagan J
Clin Microbiol Infect; 2008 Apr; 14(4):330-6. PubMed ID: 18190571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
